TrialVascular health and risk management2014

A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.

Mohamed Hassanein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.